{"brief_title": "Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women", "brief_summary": "The purpose of this study is to test the safety and effectiveness of two different formulations of an HIV vaccine in infants born to HIV-infected women.", "condition": "HIV Seronegativity", "intervention_type": "Biological", "intervention_name": "MN rsgp120/HIV-1", "criteria": "Inclusion Criteria Infants may be eligible for this study if they: - Are 1 to 3 days old.", "gender": "All", "minimum_age": "N/A", "maximum_age": "3 Days", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00000809.xml"}